Growth suppressing factor for endothelial cells exhibits tumor regressing activity.
Endothelium growth suppressing and tumor-regressing activities were copurified from the conditioned medium of P388D1 culture in the presence of 100 microg/ml carboxymethylated curdlan by a procedure including ammonium sulfate fractionation and six column chromatographies of Ceramic hydroxyapatite, Q-Sepharose, Sephacryl S-300 HR, Matrex PBA-30, PBE94, and anti-bovine serum albumin (anti-BSA) agarose. The intravenous administration of the purified growth suppressing factor for endothelial cells to sarcoma 180-bearing mouse caused a rapid decrease in the number of viable tumor cells in tumor lumps within 16 h. Immunohistochemical study showed that the intravenous injection of the purified factor to sarcoma 180-bearing mouse resulted in hemorrhagic disorder all over the tissue in the tumor lamp. Thus, the purified factor exhibited not only growth suppressing activity for endothelial cells but also tumor regressing activity at a concentration as low as about 15 ng/mouse. The purified factor significantly inhibited in vitro tubulogenesis of bovine artery, human umbilical vein, and adult human darmal microvascular endothelial cells on collagen gel at a concentration of about 5 ng/ml. After the tube formation of endothelial cells was completed on a collagen gel, the purified factor disrupted the tubes at a concentration of about 5 ng/ml within 48 h. These findings demonstrate that endothelium growth suppressing factor is a potent inhibitor of angiogenesis as well as the growth of endothelial cells, and may bring about the regression of a solid tumor by inhibiting angiogenesis.